FDA sends warning letter to Novo Nordisk over Ozempic, Wegovy side effects – WSOC TV
The Food and Drug Administration sent a warning letter to the makers of Ozempic and Wegovy for not…
Novo Nordisk Navigates Patent Expiry and Enhanced Drug Approval
Novo Nordisk gains FDA approval for potent Wegovy HD while facing generic competition in India after semaglutide patent…
FDA Approves Novo Nordisk’s Higher-Dose Wegovy for Obesity Patients
Novo Nordisk NVO announced that the FDA has approved Wegovy HD (once-weekly injectable semaglutide 7.2 mg) to reduce excess…
FDA Letter Puts Novo Nordisk GLP-1 Risks And Valuation In Focus
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
FDA Approves Novo Nordisk’s Higher-Dose Wegovy for Obesity Patients
Novo Nordisk NVO announced that the FDA has approved Wegovy HD (once-weekly injectable semaglutide 7.2 mg) to reduce excess…
Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares
Eli Lilly (LLY) is down to the $937 area as investors await an April FDA decision on its…
Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares
UrosPoteko / iStock (UrosPoteko / iStock)Quick Read Eli Lilly (LLY) is down to the $937 area as investors…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
Novo Nordisk Faces FDA Scrutiny As Hims Partnership Reshapes GLP‑1 Outlook
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
Novo Nordisk Charts a New Strategic Direction Amid Challenges
Novo Nordisk navigates FDA warnings, partners with Hims & Hers for digital sales, and expands in South America…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
Regulatory Scrutiny Intensifies for Novo Nordisk Over Drug Safety Reporting
Regulatory, Scrutiny
15.03.2026 – 03:44:25 | boerse-global.de
FDA mandates corrective action after inspection finds…